Chen, Hsing I., and Cheng Tao Hu. Endogenous nitric oxide on arterial hemodynamics: a comparison between normotensive and hypertensive rats. Am. J. Physiol. 273 (Heart Circ. Physiol. 42): H1816-H1823, 1997.-Endogenous nitric oxide (NO) plays an important role in maintaining a vasodilator tone. In the present study, we compared the effects of NO blockade on the steady and pulsatile components of arterial hemodynamics between spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto strain (WKY), 22-26 wk of age. In the first series of experiments, various doses (1-30 mg/kg iv) of N G -nitro-L-arginine methyl ester (L-NAME) were administered to block the NO release in anesthetized WKY and SHR. In both WKY and SHR, L-NAME caused a dose-dependent increase in arterial pressure (AP) with a decrease in heart rate (HR). The maximal effects of L-NAME on AP and HR occurred at a dose of 10 mg/kg. Both the AP increase and HR decrease were higher in SHR (AP, ϩ38 Ϯ 4 mmHg; HR, Ϫ49 Ϯ 5 beats/min) than WKY (AP, ϩ22 Ϯ 3 mmHg; HR, Ϫ33 Ϯ 5 beat/min). In other series, the technique of impedance spectral analysis was employed to investigate the effects of L-NAME (10 mg/kg iv) on the arterial hemodynamics. The aortic pressure and flow waves were recorded and subjected to Fourier transform for the analysis of impedance spectra. Both in WKY (n ϭ 12) and in SHR (n ϭ 12), L-NAME significantly increased AP and total peripheral resistance (TPR). The pulsatile and frequency-dependent hemodynamics including characteristic impedance, wave reflection, and ventricular work were only slightly altered. Despite higher resting values of AP and TPR in SHR (mean AP, 154 Ϯ 7 mmHg; mean TPR, 204 Ϯ 17 ϫ 10 3 dyn·s·cm Ϫ5 ) than WKY (mean AP, 94 Ϯ 6 mmHg; mean TPR, 98 Ϯ 12 ϫ 10 3 dyn·s·cm Ϫ5 ), the magnitudes of AP and TPR increments after NO blockade were significantly higher in SHR (AP, ϩ37 Ϯ 3 mmHg; TPR, ϩ124 Ϯ 16 ϫ 10 3 dyn·s·cm Ϫ5 ) than in WKY (AP, ϩ24 Ϯ 3 mmHg; TPR, ϩ45 Ϯ 7 ϫ 10 3 dyn·s·cm Ϫ5 ). The continuous formation of endogenous NO affects predominantly the AP and peripheral resistance in both WKY and SHR. The windkessel functions, such as impedance spectra, pulse-wave reflection, and ventricular work, are less affected after NO blockade. In addition, the effects of NO release on the AP and TPR appear to be enhanced in rats with established hypertension.
IT HAS BEEN WELL DOCUMENTED that continuous release of endogenous nitric oxide (NO) maintains a dilator tone in the vascular tissues (27, 28) . In isolated aortic rings (10, 14, 32, 37) and perfused vascular beds (1, 18, 39, 40) , NO blockade with N G -monomethyl-L-arginine (L-NMMA) or N G -nitro-L-arginine methyl ester (L-NAME) inevitably caused vasoconstriction. In the whole body, blockade of NO release significantly caused an increase in systemic arterial pressure (AP) (34, 36) . The increase in AP was accompanied by an increase in vascular resistance and a decrease in blood flow in various vascular beds (7) (8) (9) . There is little doubt that endothelium-derived NO formation participates in the regulation of systemic blood pressure and regional blood flow. However, a detailed analysis of the arterial hemodynamics, including the steady and pulsatile components (4, 5, 13, 31) after NO blockade, has not yet been reported.
Although hypertension is characterized by elevation of AP and peripheral vascular resistance as well as alterations in the pulsatile hemodynamics (5, 13) , the role of NO in hypertension has not been well established (3, 23, 26, 27) . Despite many studies suggesting impairment of endothelial function and NO-dependent vasorelaxation in the hypertensive state (22) (23) (24) , still other reports provide evidence against this contention (16, 20, 42, 43) .
In the present study, we used the technique of arterial impedance analysis for a complete assessment of the arterial hemodynamics (4, 5, 13, 31) . The purpose was to observe acute effects of NO blockade with L-NAME on the AP, heart rate (HR), vascular resistance, cardiac output (CO), arterial impedance, compliance, pulse-wave reflection, and ventricular work. These changes were compared between rats with normotension and long-term hypertension to elucidate the role of NO in windkessel and resistance functions and the functional alterations in hypertension.
MATERIALS AND METHODS
Animals. Spontaneously hypertensive rats (SHR) and agematched normotensive counterpart Wistar-Kyoto rats (WKY), male in sex, were used in this study. The animals were supplied by the National Animal Center and then housed in our environmentally controlled rooms. Tail cuff pressure was measured twice a week with a photoelectric volume oscillometer (Ueda, UR-5000). In SHR, the tail cuff pressure, after reaching a stage of established hypertension (22-26 wk) , was usually Ͼ180 mmHg. Repeated measurements in some SHR did not indicate a tail cuff pressure Ͼ180 mmHg, so these rats were not selected to enter the experiment.
Experimental preparation. In the first series of experiments, a total of 24 SHR and an equal number of WKY were used for the dose effects of L-NAME on the AP and HR. Rats were anesthetized with pentobarbital sodium (40 mg/kg ip). A tracheotomy was performed to provide artificial ventilation with a tidal volume of 3-5 ml and respiratory rate of 50-70 breaths/min. The femoral artery was cannulated for the recording of AP, and the femoral vein was cannulated for the administration of drugs or fluids. HR was monitored by a tachometer triggered by the arterial pulses.
Recording of the aortic pressure and flow waves for the arterial impedance analysis was carried out in 12 SHR and 12 WKY. After anesthesia and artificial respiration, the chest was opened through the left third intercostal space. An electromagnetic flow probe (model 100 series, internal circumference 7-9 mm; Carolina Medical Electronics, King, NC) was placed around the ascending aorta to measure the aortic flow. A Millar catheter with one high-fidelity pressure sensor (model SPR-407, size 2-Fr; Millar Instruments) was used to measure the aortic pressure. To minimize baseline drift, the catheter was soaked in saline at room temperature for at least 1 h before insertion. The Millar catheter was inserted via the isolated right carotid artery into the ascending aorta until the catheter tip reached a position just distal to the flow probe. Electrocardiogram (ECG) of lead II was recorded with a Gould ECG/Biotach amplifier.
The aortic pressure, flow waves, and ECG were continuously monitored with a polygraph recorder (model 2800S; Gould, Glen Burnie, MD) and also recorded on a tape recorder (model MR-30; TEAC) at a recording speed of 4.8 cm/s for off-line analysis. All data were registered after the pressure and flow signals had become stable for 3-5 min.
Arterial impedance analysis. The pressure and flow signals were digitized at 1-ms intervals using a 12-bit analog-todigital converter (model DAP 1200/4; Microstar Laboratories) interfaced to a personal computer. Selection of signals (4 consecutive beats at stable state) was made on the basis of recorded beats with optimal flow-velocity profile and beats with an R-R interval Ͻ5% different from the average value of all recorded beats during a stable state. Zero flow was assumed to be the value of flow in middle to late diastole. The largest modulus of this portion of the flow was considered to be the noise level. The calibration of the flow-velocity signal was performed after the experiment. The descending aorta was cannulated and connected to a resistor. The aortic flow was calibrated by an infusion of heparinized blood (collected from other rats) at different rates through the aorta. From the digitized flow-velocity signal, we determined a time-averaged flow velocity for at least 30 separate beats. This mean velocity was converted to volume flow by multiplying it by the cross-sectional area of the flow probe. The appropriate calibration factor for each animal was then determined by matching the CO obtained from the heparinized blood with the mean outputs calculated from the digitized flow signal. The flowmeter (model 501D; Carolina Medical Electronics) had a frequency response that was decreased by 3 dB at ϳ100 Hz. The phase lag was almost linear with frequency (1.2°/Hz). Appropriate corrections were applied at each impedance harmonic to take the phase delay into account. All hemodynamic parameters were calculated beat by beat. The average value of four beats was obtained for an individual data point.
For each beat, the impedance modulus was the ratio of the aortic pressure harmonic to the flow harmonic. The flow phase was subtracted from the pressure phase at each harmonic to yield the impedance phase angle. Any flow harmonic with a modulus Ͻ1.5 times the noise was not used for impedance calculation. The characteristic impedance (Z c ) was the average of impedance moduli in the frequency range of 15-45 Hz with coefficients of variation Ͻ10%. First zero crossing of impedance phase angle ( f 0 ) was evaluated by the linear interpolation method (4, 38) . Systolic, diastolic, and mean aortic pressures, HR, stroke volume (SV), and total peripheral resistance (TPR) were also determined for each beat. CO was the product of SV and HR. Because of a curvilinear relationship between pressure and intravascular volume in the arterial tree, any acute increase in pressure was associated with reduced compliance (19, 21) . The arterial compliance (C) at pressure (P; systolic, diastolic, or mean aortic) was obtained from the equation given by Liu et al. (21) for an exponential pressure-volume relationship
where SV is stroke volume, K is the ratio of total area under the aortic pressure curve to the diastolic area, b is the coefficient in the pressure-volume relationship and is nearly constant for different arterial segments [Ϫ0.0131 (0.009) in aortic arch], P* s is the pressure at the time of incisura, and P d is the end-diastolic pressure. Total external power (W t ), consisting both of pressure and of kinetic terms for the left ventricle, was calculated (25) . We also evaluated the oscillatory power (W o ), the steady power (W s ), and the ratio of oscillatory to total power (W o / W t ) as an index for the efficiency with which the pulsatile energy was converted into forward flow. Finally, we decomposed the measured pressure and flow waves into their forward and backward components (41)
where P m is the measured pressure wave; P f and P b are the pulse magnitudes of the forward and backward pressure components, respectively; Q m is the measured flow wave; and Q f and Q b are the forward and backward flow-wave components, respectively. Thus the measured pressure and flow waves are equal to the sum of a forward and a backward wave. The pulse magnitudes of the forward and backward components along with the ratio of the backward to the forward magnitude were used to characterize the wavereflection properties. All data and derived hemodynamic parameters were calculated and analyzed by computer programs developed in our laboratory. The measurements of aortic pressure and flow with the arterial impedance analysis in small animals like rats were essentially similar to those procedures described previously (5, 13, 45) . Because the Millar catheter (size 2-Fr) used in small animals is only equipped with a pressure sensor for monitoring the aortic pressure, the measurement of aortic flow requires open-chest surgery to place an electromagnetic flow probe around the aorta. The procedures caused a fall in AP as reported in another study (45) . How much the surgical procedures and blood pressure reduction will affect the hemodynamic data is not certain. Thus we discarded the data in which the fall in AP was Ͼ15 mmHg after thoracotomy and flow-probe placement both in WKY and in SHR. Although the selection could minimize the effects of hemodynamic perturbation, the results only pertained to measurements in the open-chest condition both in WKY and in SHR.
Experimental protocol and statistical analysis. An NO synthase inhibitor, L-NAME (Sigma) was used to block the endogenous NO (9, 27, 36) . It was dissolved in saline solution to a concentration of 20 mg/ml. The drug was delivered intravenously by a slow bolus injection (0.1 ml/5 s).
In the first series of experiment, the optimal doses of L-NAME for WKY and SHR were tested. Four doses of L-NAME (1, 5, 10, and 30 mg/kg) were administered intravenously in eight separate groups of WKY (n ϭ 6 for each dose) and SHR (n ϭ 6 for each dose) to observe the changes in AP and HR. The dose-response histogram (Fig. 1) indicated that L-NAME caused a maximal increase in AP and a decrease in HR at a dose of 10 mg/kg.
Because of the complexity of arterial impedance analysis, only one dose (10 mg/kg) was given to WKY (n ϭ 12) and SHR (n ϭ 12) in the second series of experiments. Vehicle injection (saline, 0.2-0.5 ml) did not induce discernible changes. At a steady state (5-15 min) after L-NAME, the AP and flow wave were obtained for the analysis of hemodynamic parameters.
The data were expressed as means Ϯ SE. Statistical evaluation of the dose-response relationship was done with analysis of variance and Scheffé's test. A paired t-test was used for comparisons of hemodynamic parameters between the control and experimental values. Differences were considered significant at P values Ͻ0.05.
RESULTS

Dose-dependent changes in AP and HR.
In the first series of experiments, the average baseline mean AP values (MAP) and HR were 96 Ϯ 4 mmHg and 328 Ϯ 5 beats/min in WKY (n ϭ 24) and 158 Ϯ 6 mmHg and 374 Ϯ 8 beats/min in SHR (n ϭ 24). Both MAP and mean HR were significantly higher in SHR than WKY. L-NAME in various doses (1, 5, 10, and 30 mg/kg) caused an increase in AP with a decrease in HR in both WKY and SHR (Fig. 1) . The changes after 1, 5, and 10 mg/kg were dose dependent (P Ͻ 0.01). However, the pressor and bradycardic responses to a dose of 30 mg/kg were not different from those to a dose of 10 mg/kg (P Ͼ 0.01). Furthermore, both the pressor and bradycardic effects of L-NAME (5, 10, and 30 mg/kg) were significantly greater in SHR than in WKY (P Ͻ 0.05). At a dose of 10 mg/kg, the increases in AP were 38 Ϯ 4 mmHg in SHR and 22 Ϯ 3 mmHg in WKY; the decreases in HR were 49 Ϯ 5 beats/min in SHR and 33 Ϯ 5 beats/min in WKY.
Hemodynamics of steady components. Figure 2 illustrates the recording of aortic pressure and flow signals in one WKY and one SHR. The measured and calculated hemodynamic parameters of steady components, including AP, pulse pressure (PP), HR, SV, CO, and TPR, are summarized in Table 1 . L-NAME inevitably caused increases in AP and TPR both in WKY and in SHR. In particular, TPR was elevated by 46% in WKY and 61% in SHR. The HR was slightly decreased by 9% in WKY and 12% in SHR. SV was not significantly changed, whereas CO was decreased in both groups because of the decrease in HR.
Hemodynamics of pulsatile components. Figure 3 illustrates the impedance modulus and impedance Fig. 1 . Dose effects of N G -nitro-L-arginine methyl ester (L-NAME) on arterial pressure (AP) and heart rate (HR). * Significantly different from corresponding value at previous dose (P Ͻ 0.05); ‡ significant difference in changes between Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) (P Ͻ 0.05). Note that changes between 10 and 30 mg/kg are not significantly different (P Ͼ 0.01). Fig. 2 . Recording of aortic pressure and flow waves in 1 WKY and 1 SHR after vehicle injection (left) and after a dose of L-NAME at 10 mg/kg (right). Aortic pressure is elevated both in WKY and in SHR. After L-NAME, magnitude of flow wave is slightly decreased, whereas width is slightly increased. phase in one WKY and one SHR with a vehicle injection and after L-NAME. In SHR, the impedance modulus was discernibly elevated in comparison with WKY. In addition, the phase angle was shifted to the right. However, L-NAME did not significantly affect the impedance modulus in SHR after 15 Hz, whereas it slightly elevated the level in WKY. The impedance phase did not appear to be changed by L-NAME both in WKY and in SHR. L-NAME remarkably increased the impedance modulus only at 0 Hz, which is the value corresponding to TPR. Table 2 summarizes the effects of L-NAME on pulsatile hemodynamics in WKY and SHR. Z c was slightly increased by L-NAME in WKY (ϩ18%) but not in SHR. L-NAME decreased the arterial compliance (diastolic, systolic, and mean) by 11-12% in WKY and by 19-27% in SHR. Pulse-wave reflection (expressed as P b ) was slightly increased in WKY (ϩ13%) and SHR (ϩ14%). Both in WKY and in SHR, the other parameters including f 0 , W o , and W s were not significantly altered after L-NAME administration.
WKY versus SHR. This and other previous studies (5, 13) showed that SHR had higher AP, HR, TPR, Z c , f 0 , W o , W s , P b , and P f than WKY, whereas SV, CO, and arterial compliance were lower in SHR than in WKY (Tables 1 and 2 ). The differences in response to L-NAME (10 mg/kg) between WKY and SHR are summarized in Fig. 4 . The most striking findings were the higher magnitudes of increase in AP and TPR (MAP, ϩ37 Ϯ 3 mmHg; TPR, ϩ124 Ϯ 16 ϫ 10 3 dyn·s·cm Ϫ5 ) in SHR than the corresponding values in WKY (MAP, ϩ26 Ϯ 4 mmHg; TPR, ϩ45 Ϯ 7 ϫ 10 3 dyn·s·cm Ϫ5 ). It should be noted that the AP and TPR increases in SHR changed from much higher baseline values in comparison with those in WKY. In the first series of experiments (Fig. 1) , we similarly observed that L-NAME at 5, 10, and 30 mg/kg caused higher magnitudes of AP rise in SHR than in WKY. Although the differences in AP between SHR and WKY were not statistically different at a dose of 1 mg/kg, the changes in SHR also appeared to be slightly higher than those in WKY.
In addition to the difference in AP and TPR changes between SHR and WKY, the decreases in HR and CO were also greater in SHR than in WKY. On the other hand, the increase in Z c was higher in WKY than in SHR (Fig. 4) .
DISCUSSION
Pulsatile and steady hemodynamics. It has been well documented that the release of NO maintains a dilator tone in the small arterioles as well as in the aortic segments and large arteries (1, 10, 14, 18, 27, 28) . With respect to the effects on the arterial resistance, several studies with the measurement of regional blood flow or with arterial perfusion demonstrated that acute NO blockade caused a decrease in blood flow and an increase in resistance in various vascular beds (1, (7) (8) (9) ). In the current study, we found that L-NAME elevated the TPR by 46 and 61% in WKY and SHR, respectively. The arterial hypertension after L-NAME was characterized by this marked increase in TPR with a slight decrease in CO. The reduction in CO was in turn the result of a decrease in HR without a significant change in SV. The vasoconstrictive effect of NO synthase inhibition may be attributed to blockade of NO release from not only the endothelium but also the perivascular nitroxidergic nerves. Recent studies in dogs and monkeys (30, 44) have demonstrated the presence of nerve fibers containing NO synthase in the arterial wall. This nitroxidergic nervous system can be activated by a ganglionic stimulant (nicotine) to cause NO release and vasodilatation. On the other hand, NO synthase inhibitors and ganglionic blocking agents produce nerve inhibition and vasoconstriction. The systemic administration of L-NAME might affect both endothelium-and nerve-derived NO. However, it has been suggested that vasodilation mediated by neurogenic NO in rats is not as significant as that in dogs and monkeys (30, 33) .
With respect to the hemodynamics of pulsatile components, we found that L-NAME increased Z c in WKY but not in SHR. P b was increased in both groups; however, it should be noted that the changes were relatively small compared with the big increases in TPR and AP. It was quite surprising that our results revealed a 
Values are means Ϯ SE; n, no. of rats. WKY, Wistar-Kyoto rats; SHR, spontaneously hypertensive rats; PP, pulse pressure; HR, heart rate; SV, stroke volume; CO, cardiac output; TPR, total peripheral resistance; L-NAME, N G -nitro-L-arginine methyl ester; ⌬, change; NS, not significant.
relatively weak action of L-NAME on the arterial impedance and pulse-wave reflection. These pulsatile hemodynamic components reflected mainly the changes of viscoelastic properties of the aorta and large arteries (4, 5, 13, 25, 31) . It appeared that our findings were somehow not in agreement with the results of many studies in which NO blockade was shown to cause profound constriction of the aortic segments and/or large arteries (6, 34, 36, 37) . In particular, Faraci (6) compared the acute effects of NO blockade on the constrictor responses between large arteries and small arterioles in the cerebral circulation of anesthetized rats. In a cranial window preparation, he found that topical application of NO blocker caused contraction of the large arteries by 10.4%. In contrast, the diameter of the small arterioles was only reduced by 3.7%. These findings led to a conclusion that NO release in the cerebral circulation had a greater influence on basal tone in large arteries than in small arterioles. The conclusion seems to contradict the results of the present study and is subject to discussion. First, whether the same finding can be applied to the other vascular bed is not known. Rees et al. (35) observed diameter changes in the microcirculation of the hamster cheek pouch. They found that NO caused potent dilation, whereas NO blockade produced strong constriction of the small arterioles (8-35 µm) . These findings, taken together with the studies in regional vascular beds (1, 7-10, 14, 18, 37) , indicate that NO exerts potent effects on the arteriolar resistance vessels. Second, because the vascular resistance is inversely proportional to the fourth power of the radius, a small constriction in the arterioles can produce a great increase in the vascular resistance. Finally, it should be noted that the above experiment (6) was done by topical application of the NO blocker in different sections of the pial vessels. The results could be different from those obtained in the whole vascular beds or in systemic circulation, particularly when NO blocker was given systemically. In this connection, Griffith and co-workers (11, 12) used the microangiographic technique to measure the diameter changes in the perfused rabbit ear arterial system. An intra-arterial infusion instead of topical application was used for the administration of NO blocker. They found that constriction was more prominent in small arterioles than in upstream large arteries. The results indicate that interaction among various segments occurs in the arterial system. The increase in perfusion pressure due to downstream vasoconstriction may cause passive dilation and offsets the possible vasoconstriction of the upstream large vessels. Acute NO blockade might have produced some vasoconstrictive effects on the large windkessel vessels. However, a possible increase in arterial impedance was counterbalanced by the increase in diameter of the aorta and large arteries due to a rise in AP. Because Z c is inversely related to the aortic lumen (4, 19) , an increase in aortic diameter tends to reduce Z c .
Arnal et al. (2) recently reported that, after a period (4-8 wk) of chronic administration of L-NAME, the rat developed sustained hypertension. However, ventricular hypertrophy was not found in this model of hypertension. Previous studies from our laboratory (5, 13) demonstrated that the impedance factors were more important than AP and peripheral resistance in the development of ventricular hypertrophy after longterm hypertension. The relatively weak action of NO blockade on the arterial impedance, wave reflection, and ventricular work may be one of the reasons why ventricular hypertrophy did not develop in the hypertensive model of chronic NO blockade.
In summary, analysis of the arterial hemodynamics indicates that acute NO blockade with L-NAME in WKY and SHR predominantly affects the resistance vessels. The windkessel functions, pulse-wave reflection and ventricular work, are only slightly altered. Fig. 3 . Impedance modulus (top) and phase (bottom) after vehicle injection and L-NAME (10 mg/kg) in WKY and SHR. Note marked elevation in impedance modulus at 0 Hz [value for total peripheral resistance (TPR)] after L-NAME. Impedance modulus is much higher, whereas phase is shifted to right in SHR. L-NAME has little effect on modulus and phase in SHR. It only slightly elevates impedance modulus in WKY.
Normotension versus hypertension. The current and previous studies (5, 13) revealed that AP, HR, TPR, Z c , and P b were remarkably elevated in SHR compared with WKY. It was quite surprising that the magnitudes of AP and TPR increments after L-NAME were significantly higher in SHR than in WKY (Fig. 3) . Similar findings also occurred in the first series of this experiment (Fig. 1) . The rise of AP in response to L-NAME at various doses was higher in SHR than in WKY. These observations seem to be contradictory to the contention that endothelial function is impaired in hypertension (22) (23) (24) . However, the involvement of NO synthesis and release in the hypertensive state remains obscure.
An early study by Konishi and Su (15) revealed that the vasodilatory response of aortic rings to acetylcholine was not impaired in SHR compared with WKY. On the other hand, the acetylcholine-induced vasodilatation in the segments of femoral artery was greater in SHR than in WKY. Fozard and Part (7) studied the hemodynamic responses to NO blockade with various doses of L-NMMA. They found that the increases in AP and vascular resistance in renal, carotid, mesenteric, and hindquarter beds were not different between SHR and WKY. These findings led to a suggestion that a reduced NO tone in the vasculature is unlikely to be a major factor contributing to hypertension. Li and Bukoski (20) also reported that the endothelium-dependent relaxation of resistance vessels was not impaired in hypertensive rats. Our results in the present study may further suggest that NO function in the vascular beds can be enhanced in the hypertensive state and provides a compensatory mechanism to keep the blood pressure and peripheral resistance at lower levels. In fact, several recent studies have provided evidence to indicate that NO release is not impaired but enhanced in the hypertensive state. Yamazaki et al. (43) and Lacolley et al. (16) reported that NO blockade produced exaggerated pressor response in SHR compared with WKY. The phenomenon of a greater increase of AP after NO blockade appeared to occur in different ages of SHR versus WKY: 22-26 wk in the present study and 12-13, 16, and 53-54 wk in other studies (16, 43) . In addition, the inhibitory effects of an NO synthase blocker on the endothelium-dependent relaxation of the aortic rings were greater in hypertensive than in normotensive rats (17) . In the carotid artery, SHR had a lower compliance than WKY. However, the guanosine 3Ј,5Ј-cyclic monophosphate (cGMP) content in the arterial wall was Values are means Ϯ SE; n, no. of rats. Z c , characteristic input impedance; C d , C s , C m , compliances corresponding to end-diastolic, peak systolic, and mean pressure, respectively; f 0 , first zero-crossing frequency of impedance phase angle; W s , W o , W t , external power corresponding to steady, oscillatory, and total power, respectively; P b , P f , pulse magnitude of backward and forward pressure wave, respectively. Fig. 4 . Comparison of L-NAME-induced changes in mean AP (MAP), HR, stroke volume (SV), cardiac output (CO), TPR, characteristic impedance (Z c ), arterial compliance at mean pressure (C m ), and backward pulse wave (P b ) between WKY and SHR. Increases in MAP and TPR are significantly higher in SHR than in WKY. Decreases in HR and CO are also higher in SHR than in WKY. In contrast, increase in Z c is greater in WKY than in SHR. * P Ͻ 0.05; † P Ͼ 0.05 (not significant).
much greater in SHR than in WKY. Removal of the endothelium caused a greater reduction of cGMP in SHR than in WKY, suggesting the ''cGMP pathway'' was more active in SHR compared with WKY (29). Xiao and Pang (42) further reported that the macrophages and vascular smooth cells from SHR produced a significantly higher amount of NO compared with those from WKY. They suggested that a generalized activation of the NO synthesis system that occurred in SHR may be an important factor contributing to lymphocyte depression and blood pressure control. These findings are in agreement with the results of the present study in which we find that the basal release of NO is not impaired but enhanced in rats with hypertension. In addition to the AP and vascular resistance, the decreases in HR and CO were higher in SHR than those in WKY. On the other hand, the increase in Z c was lower in SHR than in WKY.
In summary, our results indicate that the basal release of NO predominantly affects the resistance functions in both SHR and WKY. The windkessel functions are only slightly affected. Furthermore, the effects of NO on the AP and peripheral resistance are not impaired but enhanced in the hypertensive state.
